Kadcyla
NICE rejects Kadcyla
April 23, 2014Sales and Marketing CDF, Cancer, Genentech, Kadcyla, NHS, NICE, Roche
NICE has delivered a severe blow to Roche by rejecting its breast cancer ‘smart bomb’ Kadcyla for NHS use in …
Kadcyla launches in UK
February 13, 2014Sales and Marketing CDF, Cancer, Kadcyla, NHS, Roche, breast
Roche’s Kadcyla, indicated to treat an aggressive form of breast cancer, has launched today in the UK.Kadcyla (trastuzumab emtansine) which …
Three new entries to Cancer Drugs Fund
February 5, 2014Research and Development, Sales and Marketing CDF, Kadcyla, NHS, Tafinlar, UK, xofigo
Three drugs – Roche’s Kadcyla, Bayer’s Xofigo and GlaxoSmithKline’s Tafinlar – have been added to England’s Cancer Drugs Fund (CDF). …
Roche’s new Herceptin jab approved by NHS
September 25, 2013Sales and Marketing Herceptin, Kadcyla, Roche, breast cancer
CHMP recommends cancer ‘smart bomb’
September 23, 2013Research and Development, Sales and Marketing CHMP, Cancer, EMA, Kadcyla, Roche
Latest content
Major funding opportunity opens for early cancer diagnostics
September 4, 2026
Androlabs receives UK authorisation for new Testavan presentation
September 4, 2026
CEPI backs African-led Bundibugyo Ebola vaccine development
September 3, 2026
Cytomos appoints life sciences executive to board
September 2, 2026
